Analysts Set agilon health, inc. (NYSE:AGL) PT at $4.03

agilon health, inc. (NYSE:AGL) has received a consensus recommendation of “Hold” from the eighteen analysts that are currently covering the stock, Marketbeat Ratings reports. Two research analysts have rated the stock with a sell rating, fourteen have assigned a hold rating and two have given a buy rating to the company. The average twelve-month price target among brokerages that have covered the stock in the last year is $4.03.

Several equities research analysts recently weighed in on the company. Sanford C. Bernstein increased their target price on agilon health from $2.50 to $3.15 and gave the company a “market perform” rating in a report on Wednesday, January 15th. Royal Bank of Canada restated an “outperform” rating and set a $3.00 target price on shares of agilon health in a report on Tuesday, November 19th. Citigroup upgraded agilon health from a “sell” rating to a “neutral” rating and increased their target price for the company from $1.75 to $2.25 in a report on Friday, January 10th. Stifel Nicolaus lowered their price target on agilon health from $7.00 to $2.00 and set a “hold” rating for the company in a research report on Tuesday, November 12th. Finally, TD Cowen lowered their price target on agilon health from $6.00 to $2.00 and set a “hold” rating for the company in a research report on Monday, November 11th.

Insider Transactions at agilon health

In related news, Director John William Wulf acquired 45,000 shares of agilon health stock in a transaction that occurred on Thursday, December 5th. The stock was bought at an average price of $2.18 per share, with a total value of $98,100.00. Following the transaction, the director now directly owns 206,133 shares in the company, valued at approximately $449,369.94. This represents a 27.93 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Diana Mckenzie acquired 12,500 shares of agilon health stock in a transaction that occurred on Monday, November 25th. The shares were bought at an average cost of $2.28 per share, with a total value of $28,500.00. Following the transaction, the director now owns 51,319 shares in the company, valued at $117,007.32. This represents a 32.20 % increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last quarter, insiders bought 90,000 shares of company stock valued at $198,100. Corporate insiders own 3.20% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Vanguard Group Inc. increased its position in agilon health by 0.9% during the 4th quarter. Vanguard Group Inc. now owns 31,112,407 shares of the company’s stock valued at $59,114,000 after buying an additional 272,787 shares in the last quarter. Capital International Investors increased its position in agilon health by 72.0% during the 4th quarter. Capital International Investors now owns 22,331,873 shares of the company’s stock valued at $42,431,000 after buying an additional 9,346,295 shares in the last quarter. State Street Corp increased its position in agilon health by 3.0% during the 3rd quarter. State Street Corp now owns 7,449,706 shares of the company’s stock valued at $29,277,000 after buying an additional 215,733 shares in the last quarter. Geode Capital Management LLC increased its position in agilon health by 0.5% during the 4th quarter. Geode Capital Management LLC now owns 6,928,724 shares of the company’s stock valued at $13,168,000 after buying an additional 35,207 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. increased its position in agilon health by 49.2% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 4,541,549 shares of the company’s stock valued at $8,629,000 after buying an additional 1,498,524 shares in the last quarter.

agilon health Trading Down 1.6 %

Shares of AGL stock opened at $3.43 on Thursday. The stock has a market capitalization of $1.41 billion, a PE ratio of -3.64 and a beta of 0.67. agilon health has a 1-year low of $1.50 and a 1-year high of $7.73. The business has a 50-day moving average of $2.69 and a 200 day moving average of $3.19. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.29 and a quick ratio of 1.29.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.